1 Global Taxifolin Market Insight Analysis
The global Taxifolin market is valued at USD 95.61 million in 2024 and will experience a CAGR of 7.32% from 2024 to 2033.
Taxifolin, also known as dihydroquercetin (DHQ), belongs to the subclass flavanonols in the flavonoids, which in turn is a class of polyphenols. This potent flavonoid is commonly found in onions, milk thistle, grapes, green tea, olive oil, and some coniferous trees in the skin. It has vitamin P activity, promotes vascular membranes, reduces allergic and inflammatory responses, and has many properties not found in most other bioflavonoids. Therefore, taxifolin has a more potent antioxidant effect than most flavonoids.
Figure Global Taxifolin Market Size (M USD) and CAGR (2024-2033)
2 Taxifolin Market Growth Drivers and Restraints
Health needs drive the growth of food industry applications: In modern food production, consumers pay more and more attention to health, and the potential health risks of synthetic food antioxidants prompt them to prefer natural antioxidants. As a natural ingredient, Taxifolin can meet the needs of food manufacturers to extend the shelf life of products and improve food quality. It is widely used in various foods such as baked goods and dairy products. It can also be added to dietary supplements as a functional ingredient, which makes its demand in the food industry continue to rise and become a key force to promote market growth.
The trend of natural products drives market development: With the change of consumer lifestyles and food consumption patterns, the demand for organic products continues to increase. They believe that natural products are safer, and when preventing health problems, safety considerations are even higher than efficacy. This change in consumer concepts has led to the booming plant-based dietary supplement market, and the Taxifolin supplement market has also benefited from it, which in turn has driven the growth of the entire Taxifolin market.
Scientific research progress highlights product advantages: A large number of studies have shown that Taxifolin has excellent antibacterial, anti-inflammatory, antifungal and antioxidant properties, and has shown potential in the treatment of various diseases such as cancer and cardiovascular disease. For example, it can inhibit the proliferation, migration and invasion of breast cancer cells. These research results not only expand the application prospects of Taxifolin in the medical field, but also further increase the market demand for it due to its characteristics of extending the shelf life in food processing, as well as its advantages such as antioxidant and anti-photoactivity in the cosmetics and pharmaceutical industries, and strongly promote the development of the market.
Low bioavailability limits the scope of application: Taxifolin has low bioavailability. The absolute bioavailability of 99% pure Taxifolin after oral administration is only 0.49%, and it is only increased to 0.75% after being made into nanodispersions. This characteristic greatly limits its application in clinical practice, making it difficult to further expand its application scenarios, which has formed a certain obstacle to market growth.
Strict regulations restrict industry development: There are differences in regulations on Taxifolin in different countries and regions, and the regulations in some regions are very strict. Taking the United States as an example, products must obtain GRAS certification to be considered safe for use. This requirement limits the number of companies in the industry, increases the difficulty for companies to enter the market, and is not conducive to the further expansion of the market scale.
The impact of the epidemic affects market demand: The COVID-19 epidemic has had a negative impact on the Taxifolin market. The epidemic has led to a reduction in demand in downstream industries. For example, food and beverage production declined in the second quarter of 2020 due to the epidemic, and the pharmaceutical market also declined. At the same time, the epidemic has also affected marketing channels, offline sales have been restricted, and some companies have failed to adapt to online marketing in a timely manner, which has hindered business development and suppressed market development.
3 Technological Innovations in the Taxifolin Market
Innovation in extraction methods and product formulations: Given the difficulty of separating taxifolin from natural raw materials and maintaining its biological activity, the industry continues to work on innovations in extraction methods and product formulations. By developing new extraction technologies, it is expected that the purity and bioavailability of taxifolin will be improved, thereby improving product quality and market competitiveness. At present, some companies have made certain progress in this regard, and are constantly exploring more efficient and environmentally friendly extraction processes to meet the market demand for high-quality taxifolin.
Exploration of nanotechnology applications: In order to solve the problem of low bioavailability of taxifolin, nanotechnology has been gradually applied to the research and development of taxifolin products. By making taxifolin into nanodispersions, its bioavailability has been improved to a certain extent. In the future, with the continuous development and improvement of nanotechnology, it is expected that the dosage form of taxifolin will be further optimized, so that it can play a greater role in the fields of medicine and cosmetics.
At present, major companies in the taxifolin market, such as Ametis JSC, Linjiang Jianwei Biotechnology Co., Ltd., Kalenika Group, ROBIOS, etc., are all focusing on the development of their core businesses, and there has been no large-scale merger and reorganization of enterprises. Each enterprise mainly enhances its competitiveness by improving production capacity, optimizing product quality, expanding market channels, etc. For example, Ametis JSC plans to produce more than 10 tons of high-purity taxol and 80 tons of arabinogalactan annually with its production base in Russia, becoming an important player in the industry in Russia.
4 Global Taxifolin Market Size by Type
For the <95% purity segment, the market revenue is projected to be 60.29 million US dollars, accounting for 63.05% of the total market revenue. This type of Taxifolin is characterized by the presence of impurities such as catechin, epicatechin, gallic acid, and other phenolic compounds. Despite its lower purity, it is widely used in the food and beverage industry due to its strong antioxidant properties, which help preserve food and extend shelf life. It is also effective in treating various diseases such as cancer, diabetes, and cardiovascular diseases. The applications of <95% purity Taxifolin include bakery products, dairy products, cereals, and beverages, where it acts as a functional ingredient to enhance health benefits.
On the other hand, the ≥95% purity segment is expected to generate a revenue of 35.33 million US dollars, representing 36.95% of the total market revenue. This high-purity Taxifolin contains only trace amounts of impurities and is highly valued in the healthcare and cosmetics industries for its superior quality and effectiveness. In healthcare, it is used as a potent antioxidant and anti-inflammatory agent to treat various medical conditions, including cancer, heart disease, Alzheimer’s disease, and diabetes. In the cosmetics industry, ≥95% purity Taxifolin is used as an anti-aging agent to reduce wrinkles, improve skin elasticity, and protect against free radical damage. Its ability to stimulate collagen production and reduce inflammation makes it a valuable ingredient in skincare formulations.
Table Global Taxifolin Market Size and Share by Type in 2024
|
Type |
Market Size (M USD) 2024 |
Market Share 2024 |
|---|---|---|
|
<95% |
60.29 |
63.05% |
|
≥95% |
35.33 |
36.95% |
5 Global Taxifolin Market Size by Application
Food & Beverages was the dominant application segment in 2024. It had a revenue of 42.29 million US dollars, accounting for 44.23% of the total global taxifolin market revenue. Taxifolin is widely used in this segment as an antioxidant, preservative, and flavoring agent. It can be found in various food products like bakery items, dairy products, cereals, and grains. Its ability to prevent food from spoilage and enhance its nutritional value makes it highly sought – after in the food industry.
The Cosmetics segment generated a revenue of 12.07 million US dollars in 2024, with a market share of 12.62%. In cosmetics, taxifolin is used as an anti – aging agent. It helps reduce wrinkles and fine lines, improves skin appearance, and protects the skin from free radical damage. With the growing demand for natural and effective skincare products, taxifolin’s use in cosmetics is expected to increase in the future.
Healthcare was another significant application area. In 2024, it contributed 35.91 million US dollars to the market revenue, holding a 37.56% market share. Taxifolin’s antioxidant and anti – inflammatory properties make it effective in treating various medical conditions such as cancer, heart disease, and Alzheimer’s disease. Its potential in improving human health has led to a high demand in the healthcare industry.
The Agriculture segment had a relatively smaller share in 2024, with a revenue of 2.26 million US dollars and a market share of 2.36%. Taxifolin is used as a plant growth regulator in agriculture. It promotes root development and improves the overall health of plants, which can increase crop yields. However, compared to other applications, its market size is still in the process of expansion.
Table Global Taxifolin Market Size and Share by Application in 2024
|
Application |
Market Size (M USD) 2024 |
Market Share 2024 |
|---|---|---|
|
Food & Beverages |
42.29 |
44.23% |
|
Cosmetics |
12.07 |
12.62% |
|
Healthcare |
35.91 |
37.56% |
|
Agriculture |
2.26 |
2.36% |
|
Others |
3.08 |
3.23% |
6 Global Taxifolin Market Size by Region
North America was the largest market for taxifolin in 2024, with a revenue of 61.51 million US dollars, accounting for 64.33% of the global market share. The United States was the major contributor within North America, with a revenue of 52.28 million US dollars, holding 84.99% of the North American market share. Canada also had a significant presence, with a revenue of 9.23 million US dollars and a 15.01% share. The strong market performance in North America can be attributed to the high demand for taxifolin in the food and beverage and healthcare industries. The region has a well – developed consumer market with a high awareness of health and wellness, which drives the consumption of taxifolin – containing products.
Europe was the second – largest market, generating a revenue of 16.80 million US dollars in 2024, with a market share of 17.58%. Russia was a major player in the European market, with a revenue of 10.90 million US dollars, accounting for 64.85% of the European market share. Ukraine and other countries also contributed to the market. Europe has a strict regulatory environment for food and healthcare products, and taxifolin that meets the regulatory requirements has a stable market demand, especially in the food supplement and pharmaceutical sectors.
China’s taxifolin market revenue in 2024 was 4.97 million US dollars, with a market share of 5.20%. Although its market share was relatively smaller compared to North America and Europe, China has great potential for growth. The country has a large population, and with the increasing awareness of health and the development of the food and healthcare industries, the demand for taxifolin is expected to rise. Additionally, China has rich raw material resources for taxifolin production, which provides a solid foundation for the development of the industry.
Japan’s taxifolin market had a revenue of 2.92 million US dollars in 2024, with a market share of 3.05%. The Japanese market has a high demand for high – quality and natural products, and taxifolin’s properties meet the requirements of the local market, especially in the cosmetics and healthcare sectors.
South Korea’s taxifolin market revenue in 2024 was 1.92 million US dollars, accounting for 2.01% of the global market share. The growth of the taxifolin market in South Korea is driven by the country’s developed cosmetics and healthcare industries. As consumers in South Korea are highly interested in skincare and health – related products, taxifolin has found a niche in these sectors.
Figure Global Taxifolin Market Size (M USD) by Region in 2024
7 Global Taxifolin Market Analysis by Major Players
Ametis JSC
Company Introduction and Business Overview:
Ametis JSC is a leading producer of Taxifolin, established in 1998 and headquartered in Russia. The company specializes in the extraction and production of high-purity Taxifolin and other natural compounds, primarily targeting the European market.
Ametis JSC’s core business focuses on the production of Taxifolin and arabinogalactan. The company’s planned production capacity enables it to produce over 10 tons of high-purity Taxifolin and up to 80 tons of arabinogalactan annually, making it one of the largest producers in Russia. Ametis JSC is known for its high-quality products and strong market presence in Europe, where it supplies Taxifolin to various industries, including food, pharmaceuticals, and cosmetics.
Products:
Ametis JSC offers Taxifolin (also known as dihydroquercetin) with high purity levels, suitable for use in food preservation, pharmaceutical formulations, and cosmetic products. Their Taxifolin is extracted using advanced technologies to ensure maximum bioavailability and effectiveness.
Market Performance in 2024:
In 2024, Ametis JSC is projected to achieve a revenue of 61.47 million US dollars, driven by its strong market position and the growing demand for high-purity Taxifolin in Europe.
Linjiang Jianwei Biotech Co. Ltd
Company Introduction and Business Overview:
Linjiang Jianwei Biotech Co. Ltd is a state-owned holding company established in 2012, headquartered in China. It is the first and only dihydroquercetin production base in China, specializing in the industrial production of Taxifolin.
Linjiang Jianwei Biotech Co. Ltd focuses on the production of Taxifolin with a purity level of <95%, primarily targeting the Asian and European markets. The company leverages its technological expertise and abundant raw material resources to produce high-quality Taxifolin, which is widely used in the food and beverage industry. Its business strategy includes expanding market share through strategic partnerships and continuous innovation in product formulations.
Products:
Linjiang Jianwei Biotech Co. Ltd offers Taxifolin extracted from larch roots, known for its strong antioxidant properties. Their product is used as a natural preservative and functional ingredient in various food and beverage applications, contributing to the overall health benefits of the products.
Market Performance in 2024:
In 2024, Linjiang Jianwei Biotech Co. Ltd is expected to generate a revenue of 20.29 million US dollars, driven by the increasing demand for natural antioxidants in the food and beverage industry.
Kalenika Group
Company Introduction and Business Overview:
Kalenika Group is a well-known manufacturer of chemicals and natural compounds, headquartered in Russia. Established with a focus on producing high-quality Taxifolin, the company has expanded its business to include other chemical products and fertilizers.
Kalenika Group’s business is centered around the production of Taxifolin with a purity level of ≥95%. The company supplies its products primarily to European and African markets, leveraging its strong manufacturing capabilities and innovative extraction technologies. Kalenika Group is known for its commitment to quality and sustainability, ensuring that its Taxifolin products meet the highest standards for use in healthcare and cosmetics.
Products:
Kalenika Group offers high-purity Taxifolin (≥95%) extracted from Siberian larch wood. Their product is used in various applications, including pharmaceutical formulations, cosmetic products, and dietary supplements, due to its potent antioxidant and anti-inflammatory properties.
Market Performance in 2024:
In 2024, Kalenika Group is projected to achieve a revenue of 2.63 million US dollars, driven by the growing demand for high-purity Taxifolin in healthcare and cosmetics.